share_log

HC Wainwright & Co. Maintains Buy on Portage Biotech, Lowers Price Target to $9

HC Wainwright & Co. Maintains Buy on Portage Biotech, Lowers Price Target to $9

HC Wainwright & Co.维持对Portage Biotech的买入,将目标股价下调至9美元
Benzinga ·  2023/08/02 06:23

HC Wainwright & Co. analyst Robert Burns maintains Portage Biotech (NASDAQ:PRTG) with a Buy and lowers the price target from $21 to $9.

HC Wainwright&Co.分析师罗伯特·伯恩斯维持波蒂奇生物技术公司(纳斯达克股票代码:PRTG)的买入,并将目标价从21美元下调至9美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发